3-Galloylquinic acid

CAS No. 17365-11-6

3-Galloylquinic acid( —— )

Catalog No. M31343 CAS No. 17365-11-6

Theogallin is an active ingredient in decaffeinated green tea extract, has cognition enhancing effect and antidepressive.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 758 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Galloylquinic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Theogallin is an active ingredient in decaffeinated green tea extract, has cognition enhancing effect and antidepressive.
  • Description
    Theogallin is an active ingredient in decaffeinated green tea extract, has cognition enhancing effect and antidepressive.
  • In Vitro
    ——
  • In Vivo
    Theogallin shows a power decreasing effect on cortical activity. Animal Model:Adult Fisher rats (6-months-old)Dosage:20 mg/kg Administration:Oral administration Result:Showed a power decreasing effect on cortical activity.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    17365-11-6
  • Formula Weight
    344.3
  • Molecular Formula
    C14H16O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Enoblituzumab

    Enoblituzumab is a humanized IgG1 κmab monoclonal antibody that recognizes human B7-H3 protein and can be used to study solid tumors such as non-small cell lung cancer (NSCLC).

  • Procyanidin C2

    Procyanidin C2 is a phenol glycoside derived from Fagopyrum dibotrys (D. Don) Hara.

  • Demethoxycurcumin

    Demethoxycurcumin is a potential additive natural product in combination with chemotherapeutic agents in drug-resistant cancers.